Symbols / ADTX
ADTX Chart
About
Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 922.11K |
| Enterprise Value | 4.67M | Income | -42.24M | Sales | 5.95K |
| Book/sh | -151.87 | Cash/sh | 0.29 | Dividend Yield | — |
| Payout | 0.00% | Employees | 26 | IPO | — |
| P/E | — | Forward P/E | -0.05 | PEG | — |
| P/S | 155.11 | P/B | -0.00 | P/C | — |
| EV/EBITDA | -0.23 | EV/Sales | 786.37 | Quick Ratio | 0.02 |
| Current Ratio | 0.02 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -829.59 | EPS next Y | -11.29 | EPS Growth | — |
| Revenue Growth | -89.10% | Earnings | 2023-11-14 17:00 | ROA | -61.70% |
| ROE | — | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | -4198.70% | Profit Margin | 0.00% | Shs Outstand | 1.78M |
| Shs Float | 510.20K | Short Float | 2.81% | Short Ratio | 0.01 |
| Short Interest | — | 52W High | 2542.50 | 52W Low | 0.50 |
| Beta | 1.51 | Avg Volume | 2.82M | Volume | 104.47K |
| Target Price | — | Recom | None | Prev Close | $0.51 |
| Price | $0.52 | Change | 1.80% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.52
Latest analyst target
3. DCF / Fair value
$-98.86
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.52
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-09-06 | main | HC Wainwright & Co. | Buy → Buy | $61 |
- $ADTX stock is up 16% today. Here's what we see in our data. - Quiver Quantitative Fri, 16 Jan 2026 08
- Aditxt (Nasdaq: ADTX) outlines bitXbio plan, Pearsanta 2026 IPO and Evofem stake - Stock Titan ue, 18 Nov 2025 08
- Aditxt Holders Approve Share Issuances, Reverse Split Flexibility - The Globe and Mail Sun, 15 Feb 2026 08
- Aditxt Stock Plummets -55% With 7-Day Losing Streak - Trefis Sat, 22 Nov 2025 08
- What Sparked Aditxt (ADTX) Stock's 52% After‑Hours Surge? - Benzinga Wed, 17 Dec 2025 08
- Aditxt (ADTX) Stock Surges After Proxy Filing Sets Up Reverse Split Vote and “bitXbio” Name Change — What to Know on Dec. 17, 2025 - TechStock² Wed, 17 Dec 2025 08
- ADTX Stock Shows Energetic Gains as New Financial Strategies Emerge - StocksToTrade Wed, 21 Jan 2026 08
- Aditxt shares fall on 1-for-250 reverse stock split - MSN Sat, 03 Jan 2026 08
- Morning Market Movers: SMX, ADTX, TMC, CDT See Big Swings - RTTNews Fri, 28 Nov 2025 08
- ADTX stock plunges to 52-week low, touches $1.5 amid steep decline - Investing.com Fri, 30 May 2025 07
- Aditxt, Inc. Adjourns Special Meeting for Additional Voting Time - TradingView Fri, 30 Jan 2026 08
- Why Aditxt Inc. (ADTX) Went Down On Thursday? - Yahoo Finance hu, 10 Apr 2025 07
- Aditxt (NASDAQ: ADTX) implements 1-for-113 reverse split effective at market open - Stock Titan Wed, 29 Oct 2025 07
- With Aditxt Stock Sliding, Have You Assessed The Risk? - Trefis Sun, 21 Dec 2025 08
- Aditxt adjourns special shareholder meeting, sets new date for February 13 - Investing.com Fri, 30 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | — | Sale at price 1.75 per share. | BRADY BRIAN MICHAEL | Director | — | 2025-12-17 00:00:00 | D |
| 1 | 1 | 3 | — | Sale at price 2.63 per share. | PANKOVCIN CORINNE D | Officer | — | 2025-11-25 00:00:00 | D |
| 2 | 25534 | 29875 | — | Sale at price 1.17 per share. | HRT FINANCIAL L.P | Beneficial Owner of more than 10% of a Class of Security | — | 2024-10-16 00:00:00 | D |
| 3 | 15636 | 23454 | — | Purchase at price 1.50 per share. | HRT FINANCIAL L.P | Beneficial Owner of more than 10% of a Class of Security | — | 2024-10-15 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -27.45M | -25.46M | -24.28M | -26.96M |
| TotalUnusualItems | 414.50K | 0.00 | -543.94K | -17.00M |
| TotalUnusualItemsExcludingGoodwill | 414.50K | 0.00 | -543.94K | -17.00M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -34.45M | -32.38M | -27.65M | -46.37M |
| ReconciledDepreciation | 617.25K | 542.58K | 535.98K | 476.24K |
| ReconciledCostOfRevenue | 627.47K | 756.84K | 766.78K | 77.98K |
| EBITDA | -27.04M | -25.46M | -24.83M | -43.96M |
| EBIT | -27.66M | -26.00M | -25.36M | -44.43M |
| NetInterestIncome | -7.36M | -6.38M | -2.23M | -1.94M |
| InterestExpense | 7.36M | 6.39M | 2.29M | 1.94M |
| InterestIncome | 1.45K | 10.17K | 57.35K | 3.10K |
| NormalizedIncome | -34.86M | -32.38M | -27.11M | -29.37M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -34.45M | -32.38M | -27.65M | -46.37M |
| TotalExpenses | 28.00M | 26.71M | 25.87M | 27.54M |
| TotalOperatingIncomeAsReported | -27.86M | -26.06M | -25.48M | -41.93M |
| DilutedAverageShares | 129.68K | 131.00 | 10.00 | 2.00 |
| BasicAverageShares | 129.68K | 131.00 | 10.00 | 2.00 |
| DilutedEPS | -311.18 | -249.62K | -2.77M | -23.19M |
| BasicEPS | -311.18 | -249.62K | -2.77M | -23.19M |
| DilutedNIAvailtoComStockholders | -40.35M | -32.70M | -27.69M | -46.37M |
| NetIncomeCommonStockholders | -40.35M | -32.70M | -27.69M | -46.37M |
| OtherunderPreferredStockDividend | 5.91M | 319.87K | 37.67K | |
| NetIncome | -34.45M | -32.38M | -27.65M | -46.37M |
| MinorityInterests | 573.57K | 9.61K | 0.00 | |
| NetIncomeIncludingNoncontrollingInterests | -35.02M | -32.39M | -27.65M | -46.37M |
| NetIncomeContinuousOperations | -35.02M | -32.39M | -27.65M | -46.37M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -35.02M | -32.39M | -27.65M | -46.37M |
| OtherIncomeExpense | 205.83K | 51.71K | -484.98K | -17.00M |
| OtherNonOperatingIncomeExpenses | -208.67K | 51.71K | 58.96K | |
| SpecialIncomeCharges | 0.00 | -543.94K | -17.00M | |
| OtherSpecialCharges | 2.50M | |||
| WriteOff | 0.00 | 543.94K | 14.50M | |
| GainOnSaleOfSecurity | 414.50K | 51.71K | ||
| NetNonOperatingInterestIncomeExpense | -7.36M | -6.38M | -2.23M | -1.94M |
| InterestExpenseNonOperating | 7.36M | 6.39M | 2.29M | 1.94M |
| InterestIncomeNonOperating | 1.45K | 10.17K | 57.35K | 3.10K |
| OperatingIncome | -27.86M | -26.06M | -24.94M | -27.43M |
| OperatingExpense | 27.37M | 25.95M | 25.10M | 27.46M |
| ResearchAndDevelopment | 10.89M | 7.07M | 7.27M | 5.04M |
| SellingGeneralAndAdministration | 16.48M | 18.88M | 17.84M | 22.42M |
| SellingAndMarketingExpense | 197.86K | 269.28K | 1.85M | 334.98K |
| GeneralAndAdministrativeExpense | 16.29M | 18.61M | 15.99M | 22.08M |
| OtherGandA | 16.29M | 18.61M | 15.99M | 22.08M |
| GrossProfit | -493.49K | -111.66K | 166.94K | 27.05K |
| CostOfRevenue | 627.47K | 756.84K | 766.78K | 77.98K |
| TotalRevenue | 133.99K | 645.18K | 933.72K | 105.03K |
| OperatingRevenue | 133.99K | 645.18K | 933.72K | 105.03K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 1.00 | 0.00 | 0.00 | 0.00 |
| OrdinarySharesNumber | 129.68K | 131.00 | 10.00 | 2.00 |
| ShareIssued | 129.68K | 131.00 | 10.00 | 2.00 |
| NetDebt | 4.97M | 16.08M | ||
| TotalDebt | 6.92M | 18.22M | 3.38M | 4.72M |
| TangibleBookValue | 490.44K | 16.05M | 5.10M | 9.97M |
| InvestedCapital | 6.30M | 32.23M | 5.62M | 10.99M |
| WorkingCapital | -21.41M | -18.98M | 1.10M | 5.81M |
| NetTangibleAssets | 8.86M | 16.05M | 5.10M | 9.97M |
| CapitalLeaseObligations | 1.12M | 2.04M | 2.97M | 3.91M |
| CommonStockEquity | 496.55K | 16.06M | 5.21M | 10.18M |
| PreferredStockEquity | 8.37M | 25.00 | ||
| TotalCapitalization | 8.87M | 16.06M | 5.21M | 10.29M |
| TotalEquityGrossMinorityInterest | 8.29M | 16.05M | 5.21M | 10.18M |
| MinorityInterest | -583.18K | -9.61K | 0.00 | |
| StockholdersEquity | 8.87M | 16.06M | 5.21M | 10.18M |
| TreasuryStock | 201.60K | 201.60K | 201.60K | 201.60K |
| RetainedEarnings | -168.09M | -127.74M | -95.04M | -67.35M |
| AdditionalPaidInCapital | 168.79M | 144.00M | 100.45M | 77.73M |
| CapitalStock | 8.37M | 36.00 | 108.00 | 899.00 |
| CommonStock | 130.00 | 11.00 | 108.00 | 899.00 |
| PreferredStock | 8.37M | 25.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 23.86M | 28.53M | 5.53M | 6.48M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 450.87K | 2.64M | 1.89M | 2.88M |
| OtherNonCurrentLiabilities | 1.60M | |||
| DerivativeProductLiabilities | 14.52K | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 436.35K | 1.04M | 1.89M | 2.88M |
| LongTermCapitalLeaseObligation | 436.35K | 1.04M | 1.89M | 2.77M |
| LongTermDebt | 110.04K | |||
| CurrentLiabilities | 23.41M | 25.89M | 3.64M | 3.61M |
| OtherCurrentLiabilities | 1.35M | |||
| CurrentDeferredLiabilities | 106.08K | 158.61K | 188.58K | 186.06K |
| CurrentDebtAndCapitalLeaseObligation | 6.48M | 17.18M | 1.50M | 1.85M |
| CurrentCapitalLeaseObligation | 683.35K | 999.94K | 1.09M | 1.15M |
| CurrentDebt | 5.80M | 16.18M | 409.98K | 700.43K |
| OtherCurrentBorrowings | 147.82K | 147.82K | 409.98K | 700.43K |
| CurrentNotesPayable | 5.65M | 16.03M | 0.00 | |
| PayablesAndAccruedExpenses | 15.46M | 8.55M | 1.96M | 1.58M |
| CurrentAccruedExpenses | 3.02M | 1.03M | ||
| InterestPayable | 1.89M | 387.69K | ||
| Payables | 12.44M | 7.52M | ||
| OtherPayable | 2.25M | |||
| AccountsPayable | 10.19M | 7.52M | ||
| TotalAssets | 32.14M | 44.58M | 10.74M | 16.66M |
| TotalNonCurrentAssets | 30.14M | 37.67M | 5.99M | 7.25M |
| OtherNonCurrentAssets | 289.54K | |||
| NonCurrentPrepaidAssets | 87.67K | 11.28M | 355.37K | 379.25K |
| NonCurrentDeferredAssets | 0.00 | 50.00K | 0.00 | |
| InvestmentsAndAdvances | 27.28M | 22.28M | 0.00 | |
| LongTermEquityInvestment | 27.28M | 22.28M | 0.00 | |
| InvestmentsinSubsidiariesatCost | 27.28M | 22.28M | 0.00 | |
| GoodwillAndOtherIntangibleAssets | 6.11K | 9.44K | 107.00K | 214.00K |
| OtherIntangibleAssets | 6.11K | 9.44K | 107.00K | 214.00K |
| NetPPE | 2.77M | 4.10M | 5.48M | 6.36M |
| AccumulatedDepreciation | -1.84M | -1.25M | -815.99K | -387.01K |
| GrossPPE | 4.62M | 5.35M | 6.30M | 6.75M |
| Leases | 120.44K | 120.44K | 120.44K | |
| OtherProperties | 4.06M | 4.79M | 2.58M | 6.35M |
| MachineryFurnitureEquipment | 435.14K | 435.14K | 433.08K | 403.25K |
| BuildingsAndImprovements | 2.20M | 3.16M | ||
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 2.00M | 6.91M | 4.74M | 9.42M |
| PrepaidAssets | 3.38K | 217.39K | 496.87K | 460.10K |
| Inventory | 11.24K | 745.50K | 950.09K | 494.70K |
| RawMaterials | 950.09K | 494.70K | ||
| Receivables | 1.15M | 5.85M | 527.96K | 589.84K |
| OtherReceivables | 1.11M | 5.44M | ||
| NotesReceivable | 0.00 | 500.00K | ||
| AccountsReceivable | 43.44K | 408.33K | 527.96K | 89.84K |
| AllowanceForDoubtfulAccountsReceivable | -4.00K | 0.00 | -18.63K | |
| GrossAccountsReceivable | 47.44K | 408.33K | 546.60K | |
| CashCashEquivalentsAndShortTermInvestments | 833.03K | 97.10K | 2.77M | 7.87M |
| CashAndCashEquivalents | 833.03K | 97.10K | 2.77M | 7.87M |
| CashFinancial | 833.03K | 97.10K | 2.77M | 7.87M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -16.76M | -19.22M | -22.76M | -23.29M |
| RepurchaseOfCapitalStock | -2.85M | -1.00K | -20.00K | 0.00 |
| RepaymentOfDebt | -6.01M | -3.84M | -3.29M | -914.77K |
| IssuanceOfDebt | 4.62M | 9.59M | 2.88M | 4.47M |
| IssuanceOfCapitalStock | 21.17M | 11.06M | 17.25M | 29.87M |
| CapitalExpenditure | -14.41K | -367.08K | -1.02M | |
| InterestPaidSupplementalData | 1.24M | 3.07M | 753.04K | 15.79K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 833.03K | 97.10K | 2.77M | 7.87M |
| BeginningCashPosition | 97.10K | 2.77M | 7.87M | 10.50M |
| ChangesInCash | 735.93K | -2.67M | -5.10M | -2.63M |
| FinancingCashFlow | 22.50M | 16.55M | 17.53M | 35.95M |
| CashFlowFromContinuingFinancingActivities | 22.50M | 16.55M | 17.53M | 35.95M |
| NetOtherFinancingCharges | 4.34M | -261.16K | -400.49K | -1.20M |
| ProceedsFromStockOptionExercised | 1.25M | 0.00 | 1.11M | 3.73M |
| NetPreferredStockIssuance | -2.85M | 0.00 | 0.00 | 0.00 |
| PreferredStockPayments | -2.85M | -1.00K | -20.00K | 0.00 |
| PreferredStockIssuance | 0.00 | 1.00K | 20.00K | 0.00 |
| NetCommonStockIssuance | 21.17M | 11.05M | 17.23M | 29.87M |
| CommonStockIssuance | 21.17M | 11.05M | 17.23M | 29.87M |
| NetIssuancePaymentsOfDebt | -1.40M | 5.75M | -411.89K | 3.56M |
| NetShortTermDebtIssuance | -1.40M | 5.75M | -411.89K | -315.79K |
| ShortTermDebtPayments | -6.01M | -3.84M | -3.29M | -315.79K |
| ShortTermDebtIssuance | 4.62M | 9.59M | 2.88M | |
| NetLongTermDebtIssuance | -812.38K | 3.56M | ||
| LongTermDebtPayments | -3.69M | -914.77K | ||
| LongTermDebtIssuance | 2.88M | 4.47M | ||
| InvestingCashFlow | -5.00M | -14.41K | -241.92K | -16.31M |
| CashFlowFromContinuingInvestingActivities | -5.00M | -14.41K | -241.92K | -16.31M |
| NetOtherInvestingChanges | 125.16K | -15.29M | ||
| NetInvestmentPurchaseAndSale | -5.00M | 0.00 | ||
| PurchaseOfInvestment | -5.00M | 0.00 | ||
| NetPPEPurchaseAndSale | 0.00 | -14.41K | -367.08K | -1.02M |
| PurchaseOfPPE | 0.00 | -14.41K | -367.08K | -1.02M |
| OperatingCashFlow | -16.76M | -19.20M | -22.39M | -22.28M |
| CashFlowFromContinuingOperatingActivities | -16.76M | -19.20M | -22.39M | -22.28M |
| ChangeInWorkingCapital | 7.09M | 9.10M | -493.44K | 129.97K |
| ChangeInOtherCurrentLiabilities | 667.00K | 1.60M | 0.00 | |
| ChangeInPayablesAndAccruedExpense | 5.10M | 6.65M | 412.96K | 1.33M |
| ChangeInPrepaidAssets | 232.75K | 528.43K | -12.88K | -396.80K |
| ChangeInInventory | 734.26K | 204.59K | -455.40K | -494.70K |
| ChangeInReceivables | 364.89K | 119.64K | -438.12K | -312.46K |
| ChangesInAccountReceivables | 364.89K | 119.64K | -438.12K | -312.46K |
| OtherNonCashItems | 4.21M | 2.14M | 1.53M | 1.85M |
| StockBasedCompensation | 6.75M | 1.40M | 3.13M | 4.64M |
| AssetImpairmentCharge | 0.00 | 543.94K | 14.50M | |
| DepreciationAmortizationDepletion | 617.25K | 542.58K | 535.98K | 476.24K |
| DepreciationAndAmortization | 617.25K | 542.58K | 535.98K | 476.24K |
| AmortizationCashFlow | 3.33K | 107.56K | 107.00K | 107.00K |
| AmortizationOfIntangibles | 3.33K | 107.56K | 107.00K | 107.00K |
| Depreciation | 613.92K | 435.03K | 428.98K | 369.24K |
| OperatingGainsLosses | -411.50K | 6.98K | 2.50M | |
| GainLossOnInvestmentSecurities | -414.50K | |||
| GainLossOnSaleOfPPE | 3.00K | 0.00 | 6.98K | 0.00 |
| NetIncomeFromContinuingOperations | -35.02M | -32.39M | -27.65M | -46.37M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ADTX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|